a) prostate specific antigen (PSA) is specific to the prostate but not to prostate cancer b) PSA cannot discriminate different cancer stages c) The introduction of PSA as a screening test has led to substantial 'overdiagnosis' d) PSA screening does not affect prostate cancer mortality
Wednesday, 26 March 2008 - During the past two decades, ureterorenoscopy (URS) has dramatically changed the management of ureteral calculi and is extensively used in many urological centres all over the world. Major improvements...
Filed by: Joel Vega
"What is the best treatment for calyceal stones: percutaneous nephrolithotomy or extracorporeal shockwave lithotripsy?" is the presentation of Al-Atrach et al. reporting a prospective randomized study of 60 patients with single...
By Prof. Frans Debruyne